Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00158886
Status:
TERMINATED
Last Update Posted:
2017-11-14
First Post:
2005-09-08
Brief Title:
Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2006-08-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-08-11
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-08
First Submit QC Date:
September 8 2005
Study First Post Date:
2005-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-10
Last Update Post Date:
2017-11-14
Last Update Post Date Type:
ACTUAL